M&A activity has been muted this year, but a mega-deal could now be on the cards. Horizon Therapeutics plc’ board has revealed it is the midst of “highly preliminary” discussions with Amgen, Inc., Janssen Global Services (a Johnson & Johnson company) and Sanofi which could result in an offer for its “entire share capital,” prompting optimism about potential deal value.
The Dublin-headquartered company revealed the news shortly after the Wall Street Journal reported it was fielding takeover interest from big pharma firms, in accordance with the Irish Takeover Rules
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?